Scotiabank Maintains Sector Outperform on Bio-Techne, Raises Price Target to $88
Portfolio Pulse from Benzinga Newsdesk
Scotiabank analyst Sung Ji Nam has maintained a Sector Outperform rating on Bio-Techne (NASDAQ:TECH) and raised the price target from $83 to $88.
October 31, 2024 | 7:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Scotiabank has reaffirmed its positive outlook on Bio-Techne by maintaining a Sector Outperform rating and increasing the price target from $83 to $88.
The increase in price target from $83 to $88 by Scotiabank suggests a positive outlook for Bio-Techne, likely boosting investor confidence and potentially leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100